Skip to main content

Volume 25 - Issue 3 - March 2017

03/21/2017
Dermatologists from around the world gathered in Orlando, FL, for the 75th Annual Meeting of the American Academy of Dermatology to learn about the latest news and research in the field.
Dermatologists from around the world gathered in Orlando, FL, for the 75th Annual Meeting of the American Academy of Dermatology to learn about the latest news and research in the field.
Dermatologists from around the...
03/21/2017
The Dermatologist
News
03/17/2017
While new research has tied rosacea to increased risk of a growing number of potentially serious illnesses—including cardiovascular disease, gastrointestinal disease, certain types of cancer, and more—only 18% of the estimated 16 million...
While new research has tied rosacea to increased risk of a growing number of potentially serious illnesses—including cardiovascular disease, gastrointestinal disease, certain types of cancer, and more—only 18% of the estimated 16 million...
While new research has tied...
03/17/2017
The Dermatologist
Derm Dx
08/02/2018
Benjamin Barankin, MD, FRCPC; Alexander K.C. Leung, MD, MBBS, FRCPC, FRCP
A 25-year-old man presented with mildly pruritic weeping lesions, one on each shin, for approximately one year in duration.
A 25-year-old man presented with mildly pruritic weeping lesions, one on each shin, for approximately one year in duration.
A 25-year-old man presented with...
08/02/2018
The Dermatologist
03/16/2017
At the conclusion of the American Academy of Dermatology’s annual meeting, Henry W. Lim, MD, FAAD, in practice in Detroit, Michigan, took office as president of Academy along with 1 officer and 4 new members of the Board of Directors.
At the conclusion of the American Academy of Dermatology’s annual meeting, Henry W. Lim, MD, FAAD, in practice in Detroit, Michigan, took office as president of Academy along with 1 officer and 4 new members of the Board of Directors.
At the conclusion of the...
03/16/2017
The Dermatologist
The Dermatopathologist
09/23/2017
Cynthia M. Magro, MD
In this case, the condition occurs in association with aplasia cutis congenita.
In this case, the condition occurs in association with aplasia cutis congenita.
In this case, the condition...
09/23/2017
The Dermatologist
04/08/2017
Paula E. Bermann, MSN, FNP-BC, DCNP
Certification recognizes proficiency for registered nurses and nurse practictioners.
Certification recognizes proficiency for registered nurses and nurse practictioners.
Certification recognizes...
04/08/2017
The Dermatologist
04/07/2017
Recent research suggests inpatient dermatology consultations were associated with shorter hospital stays and reduced readmissions in a US medical centers.
Recent research suggests inpatient dermatology consultations were associated with shorter hospital stays and reduced readmissions in a US medical centers.
Recent research suggests...
04/07/2017
The Dermatologist
Research in Review
04/05/2017
Jeffrey Rapaport, MD, FAAD
Platelet-rich plasma is a method for the treatment of androgenic alopecia that has shown positive results.
Platelet-rich plasma is a method for the treatment of androgenic alopecia that has shown positive results.
Platelet-rich plasma is a method...
04/05/2017
The Dermatologist
04/03/2017
Mamina Turegano, MD; Andrew Vardanian, MD; Lorraine Young, MD; Delila Pouldar, BA; Lisa Hisaw, MD
This case reports on a rare case of radiation-induced lymphangioma circumscriptum (LC) in a 68-year-old woman with a history of Hodgkin lymphoma, treated with radiation therapy to the groin and stem cell transplant 9 years prior to...
This case reports on a rare case of radiation-induced lymphangioma circumscriptum (LC) in a 68-year-old woman with a history of Hodgkin lymphoma, treated with radiation therapy to the groin and stem cell transplant 9 years prior to...
This case reports on a rare case...
04/03/2017
The Dermatologist
03/24/2017
The FDA has granted rituximab (Rituxan, Genentech) Breakthrough Therapy Designation status for pemphigus vulgaris, a rare, serious and life-threatening condition.
The FDA has granted rituximab (Rituxan, Genentech) Breakthrough Therapy Designation status for pemphigus vulgaris, a rare, serious and life-threatening condition.
The FDA has granted rituximab...
03/24/2017
The Dermatologist